OLYMPUSby New Odyssey
Menu
SEC registrant · CIK 0001479419

KALA BIO, Inc. (KALA)

KALA BIO, Inc. (CIK 0001479419, ticker KALA, EIN 27-0604595) reported revenue of $0 for FY2025 (2025-01-01 to 2025-12-31) and net income of -$26.98 million (-$26,980,000) for FY2025 (2025-01-01 to 2025-12-31), as filed in its 10-K filed 2026-04-15 (accession 0001104659-26-043782).

Figures are as filed with the SEC in XBRL, in whole US dollars unless stated, for the company's own fiscal years (fiscal year ends December 31).

Data as of Oct 21, 2026 (Olympus publication) · Markdown version

  • Values are as filed by the company in its 10-K and 10-Q XBRL data. When a later filing restates a value, the latest filed value is shown and the first reported value is noted.

Identifiers

As published in the company's EDGAR submissions record.

IdentifierValue
CIK0001479419
TickersKALA (Nasdaq)
EIN27-0604595
SIC industry code2834 Pharmaceutical Preparations
State or country of incorporationDE
Fiscal year endDecember 31
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
Olympus entity IDorg_42bx8bztqkzgx52m26n71k2q78
  • The EIN is the one the filer gave to EDGAR. The SEC does not verify it; Olympus checks only that it has nine digits and a prefix the IRS assigns.

Latest annual financial metrics

The latest annual value of each standardised metric, with the filing it was taken from.

MetricValueFiscal periodPeriodFormFiledAccession numberXBRL concept
Revenue$0FY20252025-01-01 to 2025-12-3110-K2026-04-150001104659-26-043782RevenueFromContractWithCustomerIncludingAssessedTax
Net income-$26,980,000FY20252025-01-01 to 2025-12-3110-K2026-04-150001104659-26-043782NetIncomeLoss
Total assets$9,490,000FY2025as of 2025-12-3110-K2026-04-150001104659-26-043782Assets
Total liabilities$2,494,000FY2025as of 2025-12-3110-K2026-04-150001104659-26-043782Liabilities
Stockholders' equity$6,996,000FY2025as of 2025-12-3110-K2026-04-150001104659-26-043782StockholdersEquity
Operating cash flow-$31,991,000FY20252025-01-01 to 2025-12-3110-K2026-04-150001104659-26-043782NetCashProvidedByUsedInOperatingActivities
Diluted earnings per share-$3.31 per shareFY20252025-01-01 to 2025-12-3110-K2026-04-150001104659-26-043782EarningsPerShareDiluted
Shares outstanding929,491,578 sharesFY2025as of 2026-04-1010-K2026-04-150001104659-26-043782EntityCommonStockSharesOutstanding
  • Accession numbers link to the filing's index on SEC EDGAR.

Revenue and net income history

Every annual revenue and net income value served for fiscal years 2016-2025, newest first, each with its filing.

MetricFiscal periodPeriodValueFormFiledAccession number
RevenueFY20252025-01-01 to 2025-12-31$010-K2026-04-150001104659-26-043782
RevenueFY20242024-01-01 to 2024-12-31$010-K2026-04-150001104659-26-043782
RevenueFY20232023-01-01 to 2023-12-31$010-K2025-03-310001558370-25-004081
RevenueFY20222022-01-01 to 2022-12-31$3,892,00010-K2024-03-290001558370-24-004326
RevenueFY20212021-01-01 to 2021-12-31$11,240,00010-K2023-03-030001558370-23-002746
RevenueFY20202020-01-01 to 2020-12-31$6,362,00010-K2022-03-290001558370-22-004624
RevenueFY20192019-01-01 to 2019-12-31$6,074,00010-K2021-02-250001558370-21-001797
RevenueFY20172017-01-01 to 2017-12-31$010-K2018-04-020001558370-18-002697
Net incomeFY20252025-01-01 to 2025-12-31-$26,980,00010-K2026-04-150001104659-26-043782
Net incomeFY20242024-01-01 to 2024-12-31-$38,511,00010-K2026-04-150001104659-26-043782
Net incomeFY20232023-01-01 to 2023-12-31-$42,199,00010-K2025-03-310001558370-25-004081
Net incomeFY20222022-01-01 to 2022-12-31-$44,822,00010-K2024-03-290001558370-24-004326
Net incomeFY20212021-01-01 to 2021-12-31-$142,605,00010-K2023-03-030001558370-23-002746
Net incomeFY20202020-01-01 to 2020-12-31-$104,327,00010-K2022-03-290001558370-22-004624
Net incomeFY20192019-01-01 to 2019-12-31-$94,347,00010-K2021-02-250001558370-21-001797
Net incomeFY20182018-01-01 to 2018-12-31-$66,738,00010-K2020-02-120001558370-20-000733
Net incomeFY20172017-01-01 to 2017-12-31-$42,211,00010-K2019-03-120001558370-19-001825

Recent 10-K and 10-Q filings

The 12 most recent 10-K, 10-Q and amendment filings in EDGAR, newest first.

FormFiledPeriod of reportAccession numberDocument
10-Q2026-08-192026-06-300001104659-26-098783kala-20260630x10q.htm
10-Q2026-05-152026-03-310001104659-26-062397kala-20260331x10q.htm
10-K2026-04-152025-12-310001104659-26-043782kala-20251231x10k.htm
10-Q2025-11-192025-09-300001104659-25-113927kala-20250930x10q.htm
10-Q2025-08-082025-06-300001558370-25-010853kala-20250630x10q.htm
10-Q2025-05-142025-03-310001558370-25-007763kala-20250331x10q.htm
10-K2025-03-312024-12-310001558370-25-004081kala-20241231x10k.htm
10-Q2024-11-122024-09-300001558370-24-015302kala-20240930x10q.htm
10-Q2024-08-062024-06-300001558370-24-011074kala-20240630x10q.htm
10-Q2024-05-142024-03-310001558370-24-008134kala-20240331x10q.htm
10-K2024-03-292023-12-310001558370-24-004326kala-20231231x10k.htm
10-Q2023-11-132023-09-300001558370-23-018696kala-20230930x10q.htm

Identifier registry

The company's identifiers in the Olympus identifier registry, each with how it was linked and its source.

SchemeValueHow linkedSourcePublished
SEC Central Index Key (CIK) · OLY-US-SEC-CIK0001479419published by the sourcedata.sec.gov/submissions/CIK0001479419.json2026-10-21
Employer Identification Number (EIN) · US-EIN27-0604595published by the sourceaskebsa.dol.gov/FOIA%20Files/2024/Latest/F_5500_2024_Latest.zip2026-10-22
Employer Identification Number (EIN) · US-EIN27-0604595published by the sourcedata.sec.gov/submissions/CIK0001479419.json2026-10-21

Same entity in other Olympus APIs

Records other Olympus APIs serve for this entity, linked through a published identifier (never matched on name).

APIRecordAPI pathLinked through
US Employee Benefits & Form 5500 APIsponsor/v1/form-5500/sponsors/270604595US-EIN 270604595

Former names

NameFromTo
KALA BIO, Inc.2023-08-022026-10-19
Kala Pharmaceuticals, Inc.2009-12-232023-06-23

Sources

  • EDGAR submissions (nightly bulk archive) (company profile and filings) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:f7d2a4f18cb91aae, source date 2026-10-20. https://data.sec.gov/submissions/CIK0001479419.json
  • EDGAR XBRL company facts (nightly bulk archive) (financial metrics) — U.S. Securities and Exchange Commission. EDGAR snapshot sha256:01e4045aa34d7224, source date 2026-10-20. https://data.sec.gov/api/xbrl/companyfacts/CIK0001479419.json
  • Published by Olympus on Oct 21, 2026.
  • Source data: U.S. Securities and Exchange Commission (EDGAR). Values are as filed by the registrant; Olympus does not audit or adjust them.
  • Olympus is not affiliated with or endorsed by the U.S. Securities and Exchange Commission.

Get this data from the API

The same figures, with provenance on every value, from the API (free API key, reference) or from an AI agent through the Olympus MCP server.

curl
curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001479419" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001479419/financials" -H "X-API-Key: $OLYMPUS_API_KEY"

curl -s "https://api.olympus.new-odyssey.com/v1/sec/companies/0001479419/filings?limit=12" -H "X-API-Key: $OLYMPUS_API_KEY"
MCP tool call
get_sec_company_financials {"cik":"1479419"}

On SEC EDGAR

About this data